Anti-stress activity of Propionibacterium freudenreichii: identification of a reactivative protein

Propionibacterium freudenreichii subsp. shermanii is known to prevent mutations caused by various agents such as N-methyl-N'-nitro-N-nitrosoguanidine, 9-aminoacridine, 4-nitro-quinoline-1-oxide and by UV radiation in both prokaryotic and eukaryotic cells. It was also shown to prevent or repair damage caused by H(2)O(2) or UV radiation in Salmonella typhimurium and Escherichia coli, a characteristic previously designated as reactivative effect. In order to characterise this effect at the molecular level, we have purified the active component from a P. freudenreichii cell-free extract using a combination of ammonium sulfate precipitation, anion-exchange and size-exclusion chromatography. The isolated 35 kDa protein was then identified using both N-terminal and internal peptide sequencing as a cysteine synthase. The latter was localised in the P. freudenreichii proteomic map. It is constitutively expressed but also clearly induced during adaptation to detergent and heat, but not acid, stresses. The biological meaning of cysteine synthase in the context of adaptation to oxidative and non-oxidative stresses is discussed.     

丁酸菌与老年肠道功能的相关性

丁酸菌是一种专性厌氧芽胞杆菌,是以丁酸为主要代谢产物的益生菌,可定植于人体肠道,在某种程度上与乳酸菌有协同作用,可抑制人肠道内有害菌的生长、促进营养物质的吸收、改善肠道功能等。本研究主要对丁酸菌在临床中的应用研究进展进行综述,尤其是对丁酸菌与老年人肠道功能的相关性进行阐述,并展望丁酸菌对老年慢性疾病如糖尿病、心血管疾病、老年痴呆、风湿性疾病及骨质疏松症防治的研究未来。     

Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms

Nonalcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide, both in adults and in children. NAFLD is characterized by aberrant lipid storage in hepatocytes (hepatic steatosis) and inflammatory progression to nonalcoholic steatohepatitis. Evidences so far suggest that intrahepatic lipid accumulation does not always derive from obesity. Gut microbiota has been considered as a regulator of energy homeostasis and ectopic fat deposition, suggesting its implications in metabolic diseases. Probiotics are live microbial that alter the enteric microflora and have beneficial effects on human health. Although the molecular mechanisms of probiotics have not been completely elucidated yet, many of their effects have proved to be beneficial in NAFLD, including the modulation of the intestinal microbiota, an antibacterial substance production, an improved epithelial barrier function and a reduced intestinal inflammation. Given the close anatomical and functional correlation between the bowel and the liver, and the immunoregulatory effects elicited by probiotics, the aim of this review is to summarize today's knowledge about probiotics in NAFLD, focusing in particular on their molecular and biochemical mechanisms, as well as highlighting their efficacy as an emerging therapeutic strategy to treat this condition.     

四株儿茶酚类铁载体高产菌株产消化酶活性及其益生特性

【背景】儿茶酚类铁载体对胃肠道菌群的生长代谢具有重要作用,研究儿茶酚类铁载体高产菌株的消化酶活性,挖掘其潜在益生特性具有重要意义。【目的】分析4株分离自健康成人粪样的儿茶酚类铁载体高产菌的产酶特性,通过分析菌株耐酸耐胆盐能力、粘附定殖能力、抗生素耐受性和急性毒性研究其益生特性。【方法】测定4株菌的蛋白酶、淀粉酶、脂肪酶、纤维素酶、植酸酶、乳糖酶和β-葡萄糖苷酶的酶活性。4株菌经人工模拟胃、肠液连续培养后分别计算其活菌数;分析4株菌的自凝集率、黏蛋白粘附率和表面疏水率;对小鼠连续7 d灌胃不同剂量的4株高产菌,观察并记录小鼠的一般体征,计算小鼠脏器指数,进行阳性细菌移位试验。【结果】在试验所测的7种消化酶中,E. coli Gut 07、E. coli Gut 12无蛋白酶和脂肪酶活性,B. cereus Gut 16无乳糖酶活性,E. coli Gut 20无蛋白酶活性,其余均具有。4株菌经人工模拟胃液培养6h后存活率均大于60%,转移到人工模拟肠液培养24 h后活菌数均大于初始菌落数;该4株菌具备在胃肠道中粘附定殖的能力,对大多数抗生素敏感,在浓度低于4.5×10~(11)CFU/m L、灌胃剂量为20m L/kg-bw时对小鼠无急性毒性,无阳性菌株移位现象。【结论】4株儿茶酚类铁载体高产菌株可作为潜在益生菌进行进一步的安全性和功能性研究。     

降胆固醇乳酸菌的筛选和分析比较

目的 比较7株乳酸菌各项生理特性,筛选高效、安全降解胆固醇的益生菌株,为后期开发应用奠定基础。方法 对选定菌株依次进行体外降胆固醇、胆盐水解酶（BSH）活力、人工胃肠液及胆盐耐受性、细胞粘附性能的测定和比较,并分析抗生素耐药性和抑制病原菌活性,最后利用16S rRNA基因测序确定细菌种属。结果 不同菌株各项生理指标存在差异。其中菌株ZL-2、JQI-7和PC-26的BSH酶活分别为0.010、0.015和0.030 U,可高效清除体外胆固醇,3株菌体外降解胆固醇率在58%以上;并且耐酸、耐胆盐,具备较好的HT-29细胞粘附性,不存在抗生素耐药性,可有效抑制大肠埃希菌、金黄色葡萄球菌、铜绿假单胞菌和阴沟肠杆菌生长。结论 菌株ZL-2、JQI-7和PC-26满足降胆固醇益生菌株的生物学特性,可用于进一步研究和开发。     

益生菌粉（副干酪乳酪杆菌207-27）的毒理学安全性评价

评估益生菌粉（副干酪乳酪杆菌207-27）的毒理学安全性,为其应用提供依据。

通过大鼠急性经口毒性试验、细菌回复突变试验、小鼠红细胞微核试验、小鼠精母细胞染色体畸变试验及大鼠28 d经口毒性试验研究益生菌粉（副干酪乳酪杆菌207-27）的安全性。

大鼠急性经口毒性试验结果显示,益生菌粉（副干酪乳酪杆菌 207-27）对大鼠的经口急性毒性LD₅₀均大于15.00 g/（kg•BW）,根据急性毒性分级标准属实际无毒。细菌回复突变试验、小鼠红细胞微核试验及小鼠精母细胞染色体畸变试验结果均显示阴性。大鼠28 d经口毒性试验结果表明,实验组大鼠体质量、摄食量、食物利用率、眼部状况、血液学指标、血液生化指标、脏器指数、大体及病理学检查结果与对照组相比差异均无统计学意义。

益生菌粉（副干酪乳酪杆菌207-27）具有良好的毒理学安全性。

     

乳酸杆菌S-层蛋白性质及其益生功能研究进展

乳酸杆菌为应用最早、研究最多的益生菌种之一,能够调节肠道微生物区系的平衡,增强机体的免疫力和抵抗力。S-层蛋白在乳酸杆菌黏附过程中起重要作用,因此乳酸杆菌中的S-层蛋白成为研究热点。本文对乳酸杆菌S-层蛋白的结构、分离提纯方法、基因克隆情况和益生功能做了详细阐述。     

Probiotic properties of Lactobacillus strains isolated from the feces of breast-fed infants and Taiwanese pickled cabbage

This study assessed potential probiotic Lactobacillus strains isolated from the feces of breast-fed infants and from Taiwanese pickled cabbage for their possible use in probiotic fermented foods by evaluating their (i) in vitro adhesive ability, resistance to biotic stress, resistance to pathogenic bacteria, and production of β-galactosidase; (ii) milk technological properties; and (iii) in vivo adhesive ability, intestinal survival and microbial changes during and after treatment. Five Lactobacillus isolates identified as Lactobacillus reuteri F03, Lactobacillus paracasei F08, Lactobacillus rhamnosus F14, Lactobacillus plantarum C06, and Lactobacillus acidophilus C11 that showed resistance to gastric juice and bile salts were selected for further evaluation of their probiotic properties. All the strains demonstrated the ability to adhere to Caco-2 cells, particularly, strain L. plantarum C06 and L. reuteri F03 showed satisfactory abilities, which were similar to that of the reference strain L. rhamnosus GG. The strains L. paracasei F08 and L. acidophilus C11 had the highest β-galactosidase activity. Most of the strains were resistant to aminoglycosides and vancomycin but sensitive to ampicillin, erythromycin, and penicillin. All the 5 strains elicited antibacterial activity against both Gram-positive (Bacillus cereus, Listeria monocytogenes and Staphylococcus aureus) and -negative (Escherichia coli and Salmonella enterica) pathogens. Moreover, the strains L. reuteri F03, L. paracasei F08, and L. plantarum C06 could grow rapidly in milk without nutrient supplementation and reached 10? cfu/mL after 24 h of fermentation at 37 °C. The viable cell counts of the 3 strains remained above 10? cfu/mL after 21 d of storage at 4 °C. In the animal feeding trial, the number of intestinal lactobacilli increased significantly after administration of milk fermented with the 3 strains, and the counts of fecal coliforms and Clostridium perfringens were markedly reduced. Lactobacillus strains could also survive in the ileal intestinal tissue of the treated rats. Technologically interesting Lactobacillus isolates may be used in the future as probiotic starter cultures for manufacturing novel fermented foods.     

Two-dimensional gel-based alkaline proteome of the probiotic bacterium Lactobacillus acidophilus NCFM

Lactobacillus acidophilus NCFM (NCFM) is a well-documented probiotic bacterium isolated from human gut. Detailed 2D gel-based NCFM proteomics addressed the so-called alkaline range, i.e., pH 6-11. Proteins were identified in 150 of the 202 spots picked from the Coomassie Brilliant Blue stained 2D gel using MALDI-TOF-MS. The 102 unique gene products among the 150 protein identifications were assigned to different functional categories, and evaluated by considering a calculated distribution of abundance as well as grand average of hydrophobicity values. None of the very few available lactic acid bacteria proteome reference maps included the range of pI >7.0. The present report of such data on the proteome of NCFM fundamentally complements current knowledge on protein profiles limited to the acid and neutral pH range.     

Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine

The article is mainly devoted to such representatives of gut microbiota as lactic acid bacteria and bifidobacteria, with minor accent on less frequently used or new probiotic microorganisms. Positive effects in treatment and prevention of diseases by different microbial groups, their metabolites and mechanisms of action, management and market of probiotic products are considered.